1.Intrapleural injection of natural growth factor in the treatment of malignant pleural effusions
Chinese Journal of Clinical Pharmacology and Therapeutics 1999;0(04):-
AIM: To investigate the therapeutic effects and the toxicity of intrapleural injection of natural growth factors (NGF, with main component of staphylococcal aureus enterotoxin C) in the treatment of patients with malignant pleural effusions. METHODS: Patients with histopathologically confirmed malignant pleural effusions were evaluated for treatment with NGF. Twelve patients with malignant pleural effusions received NGF pleural instilations until the end of the survey. Drugs were administered according to the following schedule: NGF 2000-2500 intrapleural injection twice weekly. The courses stopped when pleural effusions disappeared or severe toxic reactions occurred. RESULTS: A total of 12 objective responses were assessed, including 10 complete responses (83%), and 2 partial responses. Mean time of following up was 11.1 (3-25) months, 11 patients died during the visit, and the mean survival time was 10.2 months, significantly longer than that (
2.Efficacy of urethra perfusion with povidone iodine liquid in treatment of patients with chronic urethritis and prostatitis
Chinese Journal of Clinical Pharmacology and Therapeutics 1999;0(04):-
AIM: To evaluate the value of urethra perfusion using 0.5% povidone iodine liquid (PVP-I) in treatment of patients with chronic urethritis and prostatitis. METHODS: Outpatients with chronic urethritis and prostatitis were assigned to two groups randomly. 38 cases in treatment group were received urethra perfusion with 0.5 % PVP-I liquid plus minomycin, po, for two weeks. 42 cases in control group were received minomycin only. RESULTS: The rates of cure and total efficacy were better in treatment group than in control group (P
3.Clinical evaluation of prostaglandin E_1 liposome in treatment of patients with unstable angina pectoris
Chaohong XIA ; Yuwen YANG ; Xing WANG ; Yueyun CHEN
Chinese Journal of Clinical Pharmacology and Therapeutics 1999;0(04):-
0.05 )between control group and treatment group. The relapse rates of two weeks were different remarkably (P
4.Anti-inflammatory and antipyretic effects of total alkaloids of Aconitum sungpanense Hand-Mazz
Chinese Journal of Clinical Pharmacology and Therapeutics 1999;0(04):-
AIM: To study the anti-inflammatory and antipyretic effects of total alkaloids of Aconitum sungpanense Hand-Mazz (TAS). METHODS: The inflammatory models were established by injection different inflammatory agents in mice and rats, and the fever model by the intravenous injection of vaccine of typhoid and paratyphoid in rabbits. RESULTS: TAS ( 0.3 - 0.6 mg?kg -1 ,ip) inhibited the edema of hind paw induced by injection of fresh albumen, and formaldehyde in rats, the ear swelling induced by xylene in mice, and the proliferation of granule induced by injection of agar in rats. TAS lowered the temperature of feverish rabbits. CONCLUSION: TAS shows marked anti-inflammatory effect on both acute and chronic inflammation, and antipyretic effect.
5.Comparison of efficacy and safety between gatifloxacin and levofloxacin in treatment of patients with light to moderate acute lower respiratory tract infections
Chinese Journal of Clinical Pharmacology and Therapeutics 1999;0(04):-
0.05 ), bacterial clearance were 100% and 90%, and adverse reaction rates were 10%(2/20)and 10.53 % ( 2/19 ), respectively. All those adverse reactions were mainly gastrointestinal tract reactions. The abnormality of laboratory inspections associated with trial drugs happened to 4 and 5 patients in two groups. The reactions were mostly light increase of aminotransferase without effect on therapy. CONCLUSION: Gatifloxacin is an antibiotic with large antimicrobial spectrum and can be recommended to treat light to moderate acute lower respiratory tract infections.
6.Clinical study of low molecular weight heparins in treatment of chronic pulmonary heart diseases
Ailian ZHOU ; Henghua CHEN ; Liangchun TANG
Chinese Journal of Clinical Pharmacology and Therapeutics 1999;0(04):-
AIM: To investigate the effects and safe of low molecular weight heparins (LMWH) in the treatment of patients with chronic pulmonary heart diseases (CPHD) at hypercoagulability state. METHODS: 65 patients were randomly assigned to treatment group (n=33) and control group (n=32). All patients were given routine treatments. The patients of treatment group were hypodermically injected with 4 100~6 150 U of LMWH per day for 7 days as a course. RESULTS: After 7 days of the treatments, the patients of treatment group showed better curative effect and significantly increase in PaO_2 and AT-III and decrease in PaCO_2 and FIB in comparison with the patients in control group (P
7.Interference of valsartan on blood pressure and plasma angiotensin Ⅱ,aldosterone in salt sensitive essential hypertensive patients
Liqun HU ; Qiyun CAI ; Weidong WANG ; Jun LIU
Chinese Journal of Clinical Pharmacology and Therapeutics 1999;0(04):-
AIM: To investigate the interference of valsartan on blood pressure and plasma angiotensin Ⅱ (ang Ⅱ), aldosterone (ALD) in salt sensitive essential hypertensive patients. METHODS: Eighty-four adult hypertensive patients were enrolled in study, and the salt sensitivity was determined by acute intravenous salt water loading according to Sullvan's criteria. The change of blood pressure and plasma ang Ⅱ, and ALD were compared before and after the treatment. RESULTS: At the end of 2, 4, 6, and 8 weeks, patients with salt sensitive essential hypertensive (group ss) and no salt sensitive essential hypertensive (group nss) were measured. The results showed that sitting systolic blood pressure (SiSBP) was decreased by 17.5 ? 4.3 and 11.0 ? 1.4 mmHg, and sitting diastolis blood pressure (SiDSP) was decreased by 17.0 ? 3.7 and 7.3 ? 1.1 mmHg after the treatment. It was found that patients showed significantly higher plasma ang Ⅱ and lower plasma ALD in group ss and group nss. CONCLUSION: Valsartan can significantly control SiSBP and SiDBP for both groups, interfered plasma angiotensin Ⅱ and I aldosterone, and be more effective for patients with salt sensitive essential hypertensive.
8.Effects of l-menthol and its binary systems on the percutaneous penetration and the deposit effect of 5-fluorouracil
Chinese Journal of Clinical Pharmacology and Therapeutics 1999;0(04):-
AIM: To study the effects of l-menthol and its binary systems on percutaneous penetration and deposit effects of 5-fluorouracil (5-FU). METHODS: Percutaneous absorption experiment was performed on the apparatus of isolated skin, penetrated amounts of different times of 5-FU were determined, the cumulate penetrated amounts and permeation rates and increased permeation times were calculated, and the deposit effect of 5-FU was investigated. RESULTS: L-menthol of different concentrations could significantly enhance the percutaneous penetration of 5-FU, its increased permeation times were 1.25 and 1.45 and 1.37 times respectively,and the action of 5-FU with 2% l-menthol was the strongest. 5-FU with 2% and 4% l-menthol had a marked deposit effect. When some kinds of enhancers were used alone or combined with l-menthol, the percutaneous penetration of 5-FU had a significantly increase. CONCLUSION: L-menthol and its binary systems can markedly promote the percutaneous penetration and the deposit effect of 5-FU.
9.Experimental study of zhi-chuan-ling oral liquor on asthma
Baolin LIU ; Xiaohu WANG ; Yuanyuan XUAN
Chinese Journal of Clinical Pharmacology and Therapeutics 1999;0(04):-
AIM: To evaluate its pharmacodynamic effects of zhi-chuan-ling (ZCL) oral liquor, a traditional Chinese medicinal prescription, on asthma. METHODS: Asthma models of guinea pigs were established by aerosol inhalation of mixed solution of histamine and acetylcholine for the observation of effects of ZCL on the latent period of asthma attack. Some other indices were also investigated including the contraction of smooth muscle strips isolated from the trachea or intestinum ileum, and variations of the tracheal volume and the bronchotracheal perfusion in guinea pigs. RESULTS: ZCL elongated the latent period of asthma attack induced by areol inhalation of mixed solution of histamine and acetylcholine, antagonized activities against the contraction of the trachea and intestinum ileum induced by histamine or acetlcholine, and increased the tracheal volume and the bronchotracheal perfusion in ginea pigs in vitro. CONCLUTION: ZCL can reduce airway hyperresponsibility, relax bronchospasm, remit ventilation disturbance, and improve ventilatory function by its biologic activities against acetlcholin and histamine.
10.Advances in study of new antiapoptosis factor:survivin
Chinese Journal of Clinical Pharmacology and Therapeutics 1999;0(04):-
Survivin has been identified recently as a unique member of the inhibitor of apoptosis protein family. It is expressed during fetal development and in all common human cancers, but not in normal tissues. It can inhibit apoptosis induced by a variety of factors and play an important role during angiogenesis. Being a universal tumor-specific antiapoptosis inhibitor, survivin may serve as a potential target for gene-protein-based therapy of tumor.